U.S. Firm Offering Free FDA Regulatory Training Sessions in China? It s a Win/Win
Last week FDAImports.com and ExportToUsa.com.cn hosted a series of free FDA regulatory training sessions in Beijing and Shanghai, China for Chinese companies exporting FDA-regulated goods to the United States. Over 70 people attended the training sessions from over 30 companies including companies on FDA import alert, companies seeking first-time access to the U.S. market, and companies with a ...

FDA Approves NULOJIX (belatacept)
Bristol-Myers Squibb Company announced that the U.S. Food and Drug Administration approved NULOJIX, the first selective T-cell costimulation blocker indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant, in combination with basiliximab induction, mycophenolate mofetil , and corticosteroids.

FDA seeks to ease confusion on supplements
WASHINGTON (Reuters) - Health officials are seeking to clear up confusion about safety rules for dietary supplements by issuing draft guidelines for when manufacturers need to notify regulators about new ingredients.